Jessica Garlewicz

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
skin cancer
News
Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma
01/14/2025
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has...
01/14/2025
The Dermatologist
psoriatic arthritis
News
Defining Difficult-to-Treat Psoriatic Arthritis: A Scoping Review
01/07/2025
A recent scoping review highlights the challenges in defining and managing difficult-to-treat psoriatic arthritis.
A recent scoping review highlights the challenges in defining and managing difficult-to-treat psoriatic arthritis.
A recent scoping review...
01/07/2025
The Dermatologist
psoriasis
News
Study Links Psoriasis to Increased Dementia Risk
01/07/2025
A large population-based cohort study has identified a modestly increased risk of dementia in individuals with psoriasis.
A large population-based cohort study has identified a modestly increased risk of dementia in individuals with psoriasis.
A large population-based cohort...
01/07/2025
The Dermatologist
News
Stem Cell Therapy Shows Promise for Medically Refractory Crohn’s Disease
12/16/2024
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem...
12/16/2024
Advances in Inflammatory Bowel Disease Network
News
Study Highlights Increased Colorectal Cancer Risk in Primary Sclerosing Cholangitis Patients Without IBD
12/13/2024
A study presented at the American College of Gastroenterology, reveals that primary sclerosing cholangitis independently increases the risk of colorectal cancer.
A study presented at the American College of Gastroenterology, reveals that primary sclerosing cholangitis independently increases the risk of colorectal cancer.
A study presented at the...
12/13/2024
Gastroenterology
Conference coverage
Study Highlights Racial and Socioeconomic Disparities in Early-Onset Colorectal Cancer
12/13/2024
Research on racial and economic disparities underscores the urgent need for targeted interventions to promote early detection and equitable health care access.
Research on racial and economic disparities underscores the urgent need for targeted interventions to promote early detection and equitable health care access.
Research on racial and economic...
12/13/2024
Gastroenterology
Conference coverage
Low Rate of Postcolonoscopy Colorectal Cancer Found Using Novel Adjustment
12/13/2024
The proposed adjusted postcolonoscopy colorectal cancer rate provides a more accurate and reproducible standardized benchmark while minimizing heterogeneity, the investigators concluded.
The proposed adjusted postcolonoscopy colorectal cancer rate provides a more accurate and reproducible standardized benchmark while minimizing heterogeneity, the investigators concluded.
The proposed adjusted...
12/13/2024
Gastroenterology
News
Study Highlights Effectiveness of Medical Therapies for Fistulizing Crohn’s Disease
12/13/2024
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing...
12/13/2024
Advances in Inflammatory Bowel Disease Network
News
Perianal Fistulas as a First Sign of Crohn’s Disease
12/12/2024
The findings of a new study indicate that nearly 10% of patients present with a perianal fistula before their diagnosis with Crohn's disease, with an average diagnostic delay of nearly 4 years.
The findings of a new study indicate that nearly 10% of patients present with a perianal fistula before their diagnosis with Crohn's disease, with an average diagnostic delay of nearly 4 years.
The findings of a new study...
12/12/2024
Advances in Inflammatory Bowel Disease Network

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use